9MW2821 Combined With Toripalimab Injection in Subjects With Local Advanced or Metastatic Urothelial Cancer
Clinical trial NCT06079112 · RECRUITING
Trial details
- NCT number
- NCT06079112
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-27
- Primary completion
- 2026-12-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.